Vaccination: Why are some medical workers hesitant?
Europe
British pharmaceutical company
AstraZeneca informed European Union officials Friday that supplies of its coronavirus vaccine to the bloc will be "lower than originally anticipated" due to reduced production at a manufacturing site.
It would cut deliveries of its vaccine to the EU down to 31 million doses — a 60% slash — in the first quarter of the year.
The company blamed "reduced yields at a manufacturing site within our European supply chain," without giving details
The EU drug regulator is due to decide on the approval of AstraZeneca's vaccine on January 29. The company has already been granted emergency authorization in the UK.